EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.

Macdonald, Joanna; Henri, Justin; Roy, Kislay; Hays, Emma; Bauer, Michelle; Veedu, Rakesh Naduvile; Pouliot, Normand; Shigdar, Sarah.

Afiliação

Macdonald J; School of Medicine, Deakin University, Geelong, VIC 3128, Australia. jmmacd@deakin.edu.au.
Henri J; School of Medicine, Deakin University, Geelong, VIC 3128, Australia. jhenri@deakin.edu.au.
Roy K; School of Medicine, Deakin University, Geelong, VIC 3128, Australia. kislay.roy@deakin.edu.au.
Hays E; School of Medicine, Deakin University, Geelong, VIC 3128, Australia. ehays@deakin.edu.au.
Bauer M; School of Medicine, Deakin University, Geelong, VIC 3128, Australia. mbauer@deakin.edu.au.
Veedu RN; Centre for Comparative Genomics, Murdoch University, Perth, WA 6150, Australia. r.veedu@murdoch.edu.au.
Pouliot N; Perron Institute for Neurological and Translational Science, Perth, WA 6009, Australia. r.veedu@murdoch.edu.au.
Shigdar S; Department of Pathology and University of Melbourne, Melbourne, VIC 3010, Australia. normand.pouliot@onjcri.org.au.

Cancers (Basel) ; 10(1)2018 Jan 12.

Article em En | MEDLINE | ID: mdl-29329202